Stock listing
BOATS:SLXN Silexion Therapeutics Corp Stock
US listing (BOATS) of Silexion Therapeutics Corp · home listing NASDAQ:SLXN
Follow Silexion Therapeutics Corp into a list and get an email when it puts out news.
Home listing price · NASDAQ:SLXN
$0.148 USD +0.003 (+2.1%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SLXN
- Day range
- $0.145 – $0.154 USDNov 2, 2026
- Volume
- 313,463 sharesNov 2, 2026
- Market cap
- $2.15M USDAt the close on Nov 2, 2026 · price × 14.47M shares outstanding
- 52-week range
- $0.140 – $33.500 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $3.48M USDMedian day 888,200 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SLXN · Home | $0.148 USD | +0.003 (+2.1%) | 313,463 | $0.151 | $0.154 | $0.145 | $0.145 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:SLXN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.148 | +0.003 | +2.1% | $0.151 | $0.154 | $0.145 | 313,463 | |
| $0.145 | +0.003 | +2.0% | $0.142 | $0.170 | $0.140 | 731,701 | |
| $0.142 | -0.011 | -7.1% | $0.158 | $0.175 | $0.142 | 573,635 | |
| $0.153 | -0.012 | -7.5% | $0.170 | $0.170 | $0.151 | 378,897 | |
| $0.166 | -0.009 | -5.1% | $0.179 | $0.179 | $0.160 | 933,857 | |
| $0.175 | -0.014 | -7.6% | $0.176 | $0.184 | $0.168 | 1,186,516 | |
| $0.189 | +0.024 | +14.5% | $0.169 | $0.195 | $0.161 | 2,769,200 | |
| $0.165 | 0.000 | 0.0% | $0.169 | $0.180 | $0.160 | 544,900 | |
| $0.165 | +0.011 | +7.1% | $0.171 | $0.171 | $0.160 | 286,900 | |
| $0.154 | +0.001 | +0.7% | $0.153 | $0.174 | $0.153 | 1,119,100 | |
| $0.153 | 0.000 | 0.0% | $0.164 | $0.183 | $0.142 | 5,121,200 | |
| $0.153 | -0.036 | -19.0% | $0.194 | $0.194 | $0.152 | 831,600 | |
| $0.189 | +0.018 | +10.5% | $0.171 | $0.195 | $0.168 | 2,829,200 | |
| $0.171 | -0.005 | -2.8% | $0.180 | $0.180 | $0.164 | 704,900 | |
| $0.176 | -0.002 | -1.1% | $0.188 | $0.194 | $0.163 | 2,087,900 | |
| $0.178 | -0.037 | -17.2% | $0.208 | $0.208 | $0.177 | 1,268,800 | |
| $0.215 | -0.020 | -8.5% | $0.230 | $0.232 | $0.208 | 821,100 | |
| $0.235 | -0.019 | -7.5% | $0.246 | $0.250 | $0.222 | 1,512,500 | |
| $0.254 | -0.009 | -3.4% | $0.247 | $0.258 | $0.246 | 1,075,200 | |
| $0.263 | -0.003 | -1.1% | $0.269 | $0.269 | $0.253 | 999,300 | |
| $0.266 | +0.006 | +2.3% | $0.261 | $0.270 | $0.257 | 1,234,000 | |
| $0.260 | -0.019 | -6.8% | $0.270 | $0.299 | $0.260 | 2,025,100 | |
| $0.279 | +0.002 | +0.7% | $0.258 | $0.292 | $0.246 | 3,304,100 | |
| $0.277 | -0.041 | -12.9% | $0.263 | $0.277 | $0.256 | 11,701,000 | |
| $0.318 | +0.070 | +28.2% | $0.319 | $0.400 | $0.298 | 256,569,000 | |
| $0.248 | -0.012 | -4.6% | $0.262 | $0.276 | $0.240 | 77,399,300 | |
| $0.260 | +0.003 | +1.2% | $0.240 | $0.270 | $0.236 | 1,169,300 | |
| $0.257 | -0.058 | -18.4% | $0.269 | $0.281 | $0.250 | 2,355,200 | |
| $0.315 | -0.077 | -19.6% | $0.339 | $0.382 | $0.300 | 8,352,100 | |
| $0.392 | -0.152 | -27.9% | $0.492 | $0.500 | $0.328 | 32,528,500 | |
| $0.544 | +0.108 | +24.8% | $0.420 | $0.630 | $0.415 | 20,127,800 | |
| $0.436 | +0.056 | +14.7% | $0.386 | $0.449 | $0.384 | 27,811,300 | |
| $0.380 | +0.040 | +11.8% | $0.366 | $0.390 | $0.348 | 8,517,200 | |
| $0.340 | 0.000 | 0.0% | $0.340 | $0.349 | $0.322 | 2,480,300 | |
| $0.340 | -0.045 | -11.7% | $0.335 | $0.355 | $0.324 | 36,968,300 | |
| $0.385 | +0.028 | +7.8% | $0.348 | $0.400 | $0.344 | 888,200 | |
| $0.357 | -0.066 | -15.6% | $0.360 | $0.388 | $0.339 | 2,578,200 | |
| $0.423 | +0.073 | +20.9% | $0.415 | $0.487 | $0.385 | 118,949,200 | |
| $0.350 | +0.005 | +1.4% | $0.345 | $0.356 | $0.335 | 66,900 | |
| $0.345 | -0.007 | -2.0% | $0.364 | $0.364 | $0.335 | 189,000 | |
| $0.352 | 0.000 | 0.0% | $0.372 | $0.380 | $0.352 | 202,900 | |
| $0.352 | +0.001 | +0.3% | $0.360 | $0.374 | $0.352 | 127,400 | |
| $0.351 | -0.019 | -5.1% | $0.380 | $0.390 | $0.350 | 183,100 | |
| $0.370 | 0.000 | 0.0% | $0.360 | $0.390 | $0.360 | 177,700 | |
| $0.370 | +0.007 | +1.9% | $0.369 | $0.376 | $0.360 | 154,300 | |
| $0.363 | +0.003 | +0.8% | $0.370 | $0.376 | $0.353 | 76,900 | |
| $0.360 | +0.005 | +1.4% | $0.350 | $0.380 | $0.350 | 286,200 | |
| $0.355 | -0.010 | -2.7% | $0.374 | $0.374 | $0.351 | 228,400 | |
| $0.365 | -0.003 | -0.8% | $0.360 | $0.372 | $0.356 | 195,400 | |
| $0.368 | -0.026 | -6.6% | $0.377 | $0.389 | $0.360 | 271,400 | |
| $0.394 | -0.005 | -1.3% | $0.389 | $0.406 | $0.377 | 227,000 | |
| $0.399 | -0.014 | -3.4% | $0.401 | $0.410 | $0.381 | 281,000 | |
| $0.413 | -0.005 | -1.2% | $0.409 | $0.414 | $0.395 | 306,800 | |
| $0.418 | -0.004 | -0.9% | $0.407 | $0.418 | $0.387 | 326,000 | |
| $0.422 | +0.002 | +0.5% | $0.413 | $0.422 | $0.390 | 473,700 | |
| $0.420 | -0.040 | -8.7% | $0.414 | $0.420 | $0.373 | 1,036,700 | |
| $0.460 | +0.006 | +1.3% | $0.487 | $0.487 | $0.411 | 1,127,700 | |
| $0.454 | -0.581 | -56.1% | $0.439 | $0.490 | $0.430 | 4,317,600 | |
| $1.035 | -0.465 | -31.0% | $1.490 | $1.500 | $1.020 | 2,030,600 | |
| $1.500 | -0.370 | -19.8% | $1.810 | $1.844 | $1.450 | 198,100 | |
| $1.870 | +0.080 | +4.5% | $1.780 | $1.950 | $1.780 | 80,600 | |
| $1.790 | -0.010 | -0.6% | $1.800 | $1.800 | $1.680 | 33,000 | |
| $1.800 | -0.100 | -5.3% | $1.950 | $1.950 | $1.730 | 36,100 | |
| $1.900 | -0.050 | -2.6% | $1.710 | $1.990 | $1.660 | 639,300 | |
| $1.950 | +0.070 | +3.7% | $1.880 | $2.000 | $1.810 | 39,400 |
- Ticker
- BOATS:SLXN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Sep 30, 2026
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Latest deck · Aug 10, 2026
Investor Presentation (August 2026)
Investor deck · 27 slides
Latest news
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Sep 30, 2026
Closed $0.277 (-12.9%) on Sep 30, 2026
Silexion Therapeutics Announces Exercise of Warrants
Sep 29, 2026
Closed $0.318 (+28.2%) on Sep 29, 2026
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
Sep 28, 2026
Closed $0.248 (-4.6%) on Sep 28, 2026
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
Sep 9, 2026
Closed $0.35 (+1.4%) on Sep 9, 2026
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026
Closed $0.42 (-8.7%) on Aug 14, 2026
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
Aug 11, 2026
Closed $0.454 (-56.1%) on Aug 12, 2026
Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
Aug 4, 2026
Closed $1.90 (-2.6%) on Aug 4, 2026
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
Jul 29, 2026
Closed $1.60 (-34.7%) on Jul 29, 2026
Silexion Activates First Site in Phase 2/3 Trial Targeting KRAS-Driven Pancreatic Cancer (NASDAQ: SLXN)
Jul 29, 2026
Closed $1.60 (-34.7%) on Jul 29, 2026
Financings
Ordinary shares on exercise of series E warrants
Sep 29, 2026
Announced: US$837,366 · US$0.2603 a share · Warrants at US$0.2603 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital for general corporate purposes
Public offering of ordinary shares
Aug 14, 2026
Closed: US$2.5M raised · US$0.65 a share · Warrants at US$0.65 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Strengthen the balance sheet, support the Phase 2/3 trial of SIL204 and support Nasdaq continued listing compliance
Decks
Investor Presentation (August 2026)
Investor deck · 27 slides · Aug 10, 2026
Investor Presentation (February 2026)
Investor deck · 34 slides · Feb 3, 2026
Investor Presentation (August 2025)
Investor deck · 32 slides · August 2025
Investor Presentation (March 2025)
Investor deck · 32 slides · March 2025
Silexion Therapeutics Corp on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 57 in all · newest Sep 30, 2026 · oldest 2024
- Decks
- 8 decks · latest Aug 10, 2026
Where Silexion Therapeutics Corp is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SLXN · Home listing | NASDAQ | United States | USD |
| BOATS:SLXN · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Silexion Therapeutics Corp.